(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -19.29%112.33M | -9.24%252.99M | -15.98%139.18M | -24.92%278.76M | -23.72%165.66M | 65.31%371.28M | 104.54%217.17M | 26.77%224.59M | 18.97%106.17M | 16.90%177.16M |
Operating income | -19.29%112.33M | -9.24%252.99M | -15.98%139.18M | -24.92%278.76M | -23.72%165.66M | 65.31%371.28M | 104.54%217.17M | 26.77%224.59M | 18.97%106.17M | 16.90%177.16M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Depreciation and amortization | 42.44%-5.65M | 17.68%-19.49M | 13.30%-9.81M | 12.39%-23.67M | 4.97%-11.31M | 6.24%-27.02M | 11.59%-11.9M | -1.10%-28.82M | 9.75%-13.47M | -34.40%-28.5M |
Impairment and provision | ---- | -58.37%-163.91M | 34.88%-73.58M | -2,069,900.00%-103.5M | ---112.99M | -100.01%-5K | ---- | 327,813.04%75.37M | ---- | -100.03%-23K |
-Other impairment is provision | ---- | -58.37%-163.91M | 34.88%-73.58M | -2,069,900.00%-103.5M | ---112.99M | -100.01%-5K | ---- | 327,813.04%75.37M | ---- | -100.03%-23K |
Special items of operating profit | -3.44%-115.62M | 10.46%-207.37M | 4.75%-111.78M | -20.68%-231.59M | -21.67%-117.36M | -33.39%-191.91M | -32.13%-96.46M | 4.11%-143.88M | 4.02%-73M | -21.92%-150.04M |
Operating profit | 84.03%-8.94M | -72.22%-137.79M | 26.33%-55.99M | -152.52%-80.01M | -169.84%-76M | 19.70%152.34M | 452.06%108.81M | 9,151.85%127.27M | 1,239.97%19.71M | -101.44%-1.41M |
Financing cost | 6.60%-4.12M | -2.94%-8.78M | -5.56%-4.41M | 53.23%-8.53M | 61.52%-4.17M | 27.50%-18.24M | 18.68%-10.85M | 37.76%-25.16M | 44.89%-13.34M | -86.45%-40.42M |
Earning before tax | 78.38%-13.05M | -65.54%-146.57M | 24.67%-60.39M | -166.02%-88.54M | -181.84%-80.17M | 31.33%134.1M | 1,437.41%97.96M | 344.13%102.11M | 124.57%6.37M | -161.21%-41.83M |
Tax | 96.79%-172K | -1,574.00%-10.32M | -340.16%-5.36M | 1,446.15%700K | 738.72%2.23M | 96.75%-52K | 160.45%266K | -150.74%-1.6M | -162.15%-440K | 2,528.46%3.16M |
After-tax profit from continuing operations | 79.88%-13.23M | -78.61%-156.89M | 15.64%-65.75M | -165.53%-87.84M | -179.35%-77.94M | 33.37%134.05M | 1,555.93%98.23M | 359.92%100.51M | 123.52%5.93M | -156.70%-38.67M |
Earning after tax | 79.88%-13.23M | -78.61%-156.89M | 15.64%-65.75M | -165.53%-87.84M | -179.35%-77.94M | 33.37%134.05M | 1,555.93%98.23M | 359.92%100.51M | 123.52%5.93M | -156.70%-38.67M |
Minority profit | 125.49%13K | -242.86%-80K | 10.53%-51K | 411.11%56K | -39.02%-57K | 56.10%-18K | -355.56%-41K | -4,000.00%-41K | 55.00%-9K | 96.67%-1K |
Profit attributable to shareholders | 79.85%-13.24M | -78.40%-156.81M | 15.65%-65.7M | -165.56%-87.9M | -179.26%-77.89M | 33.33%134.07M | 1,554.12%98.27M | 360.03%100.55M | 123.57%5.94M | -156.67%-38.67M |
Basic earnings per share | 79.22%-0.0016 | -54.62%-0.0184 | 30.00%-0.0077 | -162.96%-0.0119 | -179.14%-0.011 | 33.10%0.0189 | 1,637.50%0.0139 | 358.18%0.0142 | 122.22%0.0008 | -157.29%-0.0055 |
Diluted earnings per share | 79.22%-0.0016 | -54.62%-0.0184 | 30.00%-0.0077 | -162.96%-0.0119 | -179.14%-0.011 | 33.10%0.0189 | 1,637.50%0.0139 | 358.18%0.0142 | 122.22%0.0008 | -157.29%-0.0055 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data